Geistlich is taking a significant step in further strengthening its position as the leader in medical regeneration. The expanded strategic alliance with ReOss® secures exclusive global marketing and distribution rights for the main product Yxoss CBR® and for their pipeline technologies. Dr. Mark Spilker, CSO of Geistlich, says: «Geistlich is looking forward to continuing and enhancing the successful partnership with ReOss®. We are excited to further integrate regeneration into digital patient workflow through application of ReOss’ cutting-edge 3D patient-specific technologies. This allows our dental customers to tailor their treatments even more individually to each patient.» 

ReOss® is a German medical device innovator in the fields of dentistry and oral and maxillofacial surgery. The company is well-known for its leading-edge CAD/CAM technologies, which utilize individual patient data to digitally create patient-specific solutions. Their 3D-printed products such as Yxoss CBR® are already successfully commercialized in Europe, USA, Australia and various other countries. Reoss’ pipeline includes promising new digital-based technologies that will be available to customers in the coming years. 

This strategic step brings the existing successful partnership for the Yxoss CBR® technology to the next level and strengthens Geistlich's strategy to remain at the forefront of technological advances in regenerative dental and maxillofacial medicine.